Recommendations on the use of systemic treatments for urticaria and atopic dermatitis during the COVID-19 pandemic: Statement of Dermatoallergy Working Group of the Turkish Society of Dermatology

Please use this identifier to cite or link to this item: http://hdl.handle.net/11452/34757

Title:	Recommendations on the use of systemic treatments for urticaria and atopic dermatitis during the COVID-19 pandemic: Statement of Dermatoallergy Working Group of the Turkish Society of Dermatology
Other Titles:	COVID-19 pandemisi süresince ürtiker ve atopik dermatitte sistemik tedavilerin kullanımına ilişkin öneriler: Türk Dermatoloji Derneği dermatoallerji çalışma grubu bildirisi
Authors:	Salman, Andaç Alper, Sibel Atakan, Nilgün Borlu, Murat Canpolat, Filiz Erdem, Teoman Erdem, Yasemin Gül, Ülker Kartal, Selda Pelin Koca, Rafet Küçük, Özlem Su Bursa Uludağ Üniversitesi/Tıp Fakültesi/Dermatoloji Anabilim Dalı. 0000-0002-0144-3263 Başkan, Emel Bülbül AAH-1388-2021 6602518817
Keywords:	Dermatology Atopic dermatitis Covid-19 Treatment Urticaria Omalizumab Metaanalysis Atopik dermatit COVID-19 Dupilumab Tedavi Ürtiker
Issue Date:	Dec-2020
Publisher:	Galenos Yayıncılık
Citation:	Salman, A. vd. (2020). "Recommendations on the use of systemic treatments for urticaria and atopic dermatitis during the COVID-19 pandemic: Statement of Dermatoallergy Working Group of the Turkish Society of Dermatology". Turkderm Turkish Archives of Dermatology and Venereology, 54(2), 71-75.
URI:	https://doi.org/10.4274/turkderm.galenos.2020.80000 https://jag.journalagent.com/turkderm/pdfs/TURKDERM_54_2_71_75.pdf http://hdl.handle.net/11452/34757
ISSN:	2717-6398 2651-5164
Appears in Collections:	Scopus TrDizin Web of Science

Files in This Item:

File	Description	Size	Format
Başkan_vd_2020.pdf		151.57 kB	Adobe PDF	View/Open

This item is licensed under a Creative Commons License

DSpace JSPUI